Overview

This case-based discussion will review and provide insight on how prostate cancer patient outcomes are improved through enhanced diagnostics, avoidance of unnecessary surgery with active surveillance, personalized surgical interventions when appropriate, and improving quality of life during and after treatment. We will discuss workflows and decision-making processes which will inform treatment options, as well as the latest advancements in prostate cancer care. Key takeaways during this live, 1.25-hour CME will be easily applied to your clinical practice.

Learning Objectives

At the conclusion of this activity, participants will be able to:

• Understand the current diagnostic tools used for the diagnosis and risk-stratification of men with prostate cancer
• Understand the role of surgical and non-operative management in men with localized prostate cancer to maximize oncologic benefit and minimize adverse effects to quality of life based on an individual's health priorities
• Discuss the importance of follow-up urologic care during and after prostate cancer treatment
• Assess the role that PCPs, surgical oncologists, urologists, and physician assistants play in prostate cancer management

Accreditation

Accreditation in support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credits AMA PRA Category 1 Credits TM (1.25 hours), Non-Physician Attendance / Participation (1.25 hours).

For more information please visit the official event page.